Ensar Halilovic Selected Research

Ensar Halilovic Research Topics

Disease

18	Neoplasms (Cancer) 05/2023 - 08/2008
5	Leukemia 03/2022 - 10/2015
3	Uveal melanoma 05/2023 - 06/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2023 - 12/2020
2	Breast Neoplasms (Breast Cancer) 12/2020 - 01/2019
2	Melanoma (Melanoma, Malignant) 01/2019 - 11/2017
1	Disease Progression 01/2022
1	Liposarcoma 01/2022
1	Genomic Instability 01/2021
1	Thrombocytopenia (Thrombopenia) 01/2021
1	Multiple Myeloma 01/2020
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2018
1	Neoplasm Metastasis (Metastasis) 11/2017
1	Colorectal Neoplasms (Colorectal Cancer) 12/2016
1	Lung Neoplasms (Lung Cancer) 11/2008
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 11/2008

Drug/Important Bio-Agent (IBA)

5	NVP-CGM097IBA 01/2021 - 05/2015
4	siremadlinIBA 03/2022 - 11/2018
4	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 09/2010 - 11/2008
3	Drug CombinationsIBA 05/2023 - 12/2016
3	venetoclaxIBA 01/2023 - 01/2020
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 05/2015
3	S63845IBA 12/2020 - 01/2019
2	Immune Checkpoint InhibitorsIBA 01/2021 - 11/2017
2	Proteins (Proteins, Gene)FDA Link 12/2020 - 10/2015
2	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2019 - 09/2010
2	Cyclin D1IBA 01/2019 - 09/2010
2	ErbB Receptors (EGF Receptor)IBA 08/2010 - 11/2008
2	Phosphotransferases (Kinase)IBA 08/2010 - 11/2008
2	Proto-Oncogene Proteins B-rafIBA 11/2008 - 08/2008
2	Mitogen-Activated Protein KinasesIBA 11/2008 - 08/2008
1	Azacitidine (5 Azacytidine)FDA Link 01/2023
1	ribociclibIBA 01/2022
1	CyclinsIBA 01/2022
1	AntigensIBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Blocking AntibodiesIBA 01/2021
1	Growth Differentiation Factor 15IBA 01/2021
1	Cyclin-Dependent Kinases (cdk Proteins)IBA 01/2019
1	S55746IBA 01/2019
1	Cyclin-Dependent Kinase Inhibitor p27IBA 01/2019
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2018
1	Fluorouracil (Carac)FDA LinkGeneric 01/2018
1	sotrastaurinIBA 06/2016
1	MTOR InhibitorsIBA 06/2016
1	Protein Kinase CIBA 06/2016
1	Mechanistic Target of Rapamycin Complex 1IBA 06/2016
1	Everolimus FDA Link 06/2016
1	LigandsIBA 11/2012
1	Phosphatidylinositols (Phosphatidylinositol)IBA 09/2010
1	mirdametinibIBA 09/2010
1	VemurafenibIBA 08/2010
1	ras ProteinsIBA 07/2010
1	Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)IBA 11/2008
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2008
1	tyrosine receptor (receptor, tyrosine)IBA 11/2008

Therapy/Procedure

10	Therapeutics 05/2023 - 08/2008
3	Drug Therapy (Chemotherapy) 01/2023 - 12/2016
1	Regimen B 01/2022
1	Immunotherapy 01/2021